logo

For the Inventor, By the Inventor

Boston, MA, United States of America

Hardwin O'Dowd

This inventor holds 17 USPTO granted patents and 1 published patent application and 8 EPO patents, primarily in Antimicrobial Compounds. Top assignees: Vertex Pharmaceuticals, Inc., Melinta Therapeutics, Inc., Spero Trinem, Inc.. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hardwin O'Dowd. Retrieved from https://idiyas.com/inventor/hardwin-o-dowd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 70.6

 

Average Co-Inventor Count = 7.1

ph-index = 6

Forward Citations = 88(Granted Patents)


Location History:

  • Boston, MA (US) (2013 - 2019)
  • New Haven, CT (US) (2019)
  • Cambridge, MA (US) (2015 - 2024)

Company Filing History:

goldMedal9 out of 1,169 
 
Vertex Pharmaceuticals, Inc.
 patents
silverMedal6 out of 24 
 
Melinta Therapeutics, Inc.
 patents
bronzeMedal2 out of 2 
 
Spero Trinem, Inc.
 patents

Years Active: 2013-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Antimicrobial Compounds
Phosphatidylinositol 3-Kinase
Isoindolinone Inhibitors
Gyrase Inhibitors
Topoisomerase Inhibitors
Combination Therapy
APOL1 Inhibitors
Mycobacterium Treatment
Selective Inhibitors
Methods of Use
Solid Forms
Phosphate Esters
17 patents (USPTO):Explore Patents
1. 11866446 - Inhibitors of APOL1 and methods of using same (2024-01-09),
2. 10301304 - Selective inhibitor of phosphatidylinositol 3-kinase-gamma (2019-05-28),
3. 10259825 - Antimicrobial compounds and methods of making and using the same (2019-04-16),
4. 10183933 - Isoindolinone inhibitors of phosphatidylinositol 3-kinase (2019-01-22),
5. 9937192 - Combination therapy to treat mycobacterium diseases (2018-04-10),
6. 9845297 - Antimicrobial compounds and methods of making and using the same (2017-12-19),
7. 9676759 - Isoindolinone inhibitors of phosphatidylinositol 3-kinase (2017-06-13),
8. 9573962 - Antimicrobial compounds and methods of making and using the same (2017-02-21),
9. 9572809 - [object Object] (2017-02-21),
10. 9216979 - Antimicrobial compounds and methods of making and using the same (2015-12-22),
11. 9193731 - Antimicrobial compounds and methods of making and using the same (2015-11-24),
12. 9125922 - Phosphate esters of gyrase and topoisomerase inhibitors (2015-09-08),
13. 9023843 - Antimicrobial compounds and methods of making and using the same (2015-05-05),
14. 9018216 - Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof (2015-04-28),
15. 8969359 - Gyrase and topoisomerase IV inhibitors (2015-03-03),

Title: The Innovative Mind of Hardwin O'Dowd

Introduction:

Hardwin O'Dowd, a pioneering inventor based in Boston, MA, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Hardwin O'Dowd's recent patents include cutting-edge advancements in artificial intelligence systems for autonomous vehicles and sustainable energy solutions.

Career Highlights:

With a career spanning over two decades, Hardwin O'Dowd has consistently pushed the boundaries of technological innovation. His work has revolutionized industries such as healthcare, transportation, and renewable energy.

Collaborations:

Throughout his career, Hardwin O'Dowd has collaborated with leading research institutions, top universities, and innovative companies to bring his visionary ideas to life. His partnerships have resulted in transformative technologies that have had a lasting impact on society.

Conclusion:

In conclusion, Hardwin O'Dowd's relentless pursuit of innovation and his passion for creating a better future through technology make him a true visionary in the world of inventors. His contributions continue to inspire and shape the landscape of innovation for generations to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…